Explore más sobre condiciones comunes de la salud oral para orientar a sus pacientes.
References
- Spruance SL et al. Antimicrob Agents Chemother 2002; 46:2238–2243.
- Trottet L et al. Int J Pharm 2005; 304:63–71.
- Hull CM. J Am Acad Dermatol 2011; 64:696.e1–e11.
- Strand A. Pediatr Dermatol 2012; 29:105–110.
- Hollmen KA et al. J Eur Acad Dermatol Venereol2002; 16:87–88.
- van Heerden JS, Vismer HF. Dermatology 1997; 194:14–18.
- Ortonne JP et al. J Eur Acad Dermatol Venereol 2006; 20:1307–1313.
- Li RY et al. Clin Drug Investig 2014; 34:223–230.
- de Chauvin MF et al. Mycoses 2007; 51:1–6.
- Kienzler JL et al. Curr Med Res Opin 2007; 23:1293–1302.
- Korting HC et al. Med Mycol 2001; 39:335–340.
- Budimulja U et al. Mycoses 2001; 44:300–306.
- Budimulja U et al. Int J Dermatol1998; 37:870–873.
- Hill S et al. Br J Dermatol 1992; 127:396–400.
PM-MX-PLD-22-00044